Do You Qualify: Belviq Cancer Side Effects Lawsuit Claim Review

A new class action lawsuit has been filed against Belviq, a weight loss drug that was approved by the FDA in 2015. The plaintiff claims the drug caused her to develop cancer and seeks $5 million in damages.

The Belviq Cancer Side Effects Lawsuit Claim Review is a review of a class action lawsuit settlement that was awarded to those who were prescribed Belviq. Read more in detail here: should i cash a class action settlement check.


What Exactly Is Belviq?

Lorcaserin was authorized by the FDA in 2012 and is marketed under the trade names Belviq and Belviq XR. Lorcaserin was created by Arena Pharmaceuticals and is produced by Eisai Inc.

Belviq is designed to be used in conjunction with other weight-loss treatments. The Belviq diet pill is a long-term therapy that works by decreasing a person’s appetite, which may lead to weight reduction. It’s intended to be taken in conjunction with a lower-calorie diet and more physical exercise.

The drug is approved for use in adults with a BMI of 30 and other conditions that may increase cardiovascular risk, such as high blood pressure, high cholesterol, or Type 2 diabetes, as well as adults with a BMI of 27 and other conditions that may increase cardiovascular risk, such as high blood pressure, high cholesterol, or Type 2 diabetes.

While lorcaserin is used to treat obesity that is linked to diabetes, high cholesterol, or high blood pressure, it is only used to treat the obesity itself, not any underlying illnesses that may have contributed to or caused obesity.

What Are the Side Effects of Belviq?

Belviq has a variety of adverse effects, just like any other medication. The following are some of the mild Belviq side effects:

  • Nausea
  • Mouth is parched
  • Headache
  • Dizziness
  • Constipation
  • Tiredness

According to WebMD, more severe but uncommon problems include easy bleeding/bruising, larger breasts, mental/mood disorders, suicidal thoughts, and low blood sugar.

Belviq has also been associated to an elevated risk of different types of cancer, leading to the drug’s maker pulling it off the market at the FDA’s request.

Was Belviq approved by the Food and Drug Administration (FDA)?

The medication was originally denied by an FDA panel in a 9-to-5 decision, according to The New York Times, because committee members were worried about the treatment’s safety and effectiveness. The fact that tumors had been discovered in rats exposed to the medication was a major source of worry.

Others on the panel were less worried about the weight-loss medication’s possible dangers and more concerned that it did not seem to be very successful in helping individuals lose weight.

Dr. Eric I. Felner, a panel member and diabetes specialist who voted against the drug’s approval, told The New York Times, “I really didn’t have a lot of concerns with the risk.” “I simply didn’t think it was very effective.”

Clinical studies revealed that individuals who took lorcaserin lost just 3.3 percent more weight than those who took a placebo. This falls short of the FDA’s 5-percentage-point effectiveness requirement.

According to The New York Times, committee member Dr. Pamela S. Douglas, professor of research in cardiovascular diseases at Duke University, said, “I don’t think the argument that there is an urgent need really mitigates the concern of putting a drug on the market that doesn’t do much and may do harm.”

The FDA’s concern stemmed from the fact that medicines like lorcaserin may be used for a long time by millions of individuals, meaning that any possible adverse effects could be amplified by long-term exposure, putting countless people at danger.

Despite its early reservations about the drug’s possible adverse effects, the FDA authorized lorcaserin only a few years later. However, the FDA ordered drugmaker Eisai Inc. to undertake a clinical safety study to monitor patients for cardiovascular risks as part of the drug’s approval in 2012.

The findings of this study were surprising, despite the fact that it was searching for possible cardiovascular issues.

What Kinds of Belviq Cancer Are There?

According to Medical News Today, a safety clinical study found that Belviq and Belviq XR patients had a greater chance of getting cancers such as lung, colon, and pancreatic cancer.

The randomized, double-blind, placebo-controlled study, which was designed to check for possible cardiovascular hazards, followed about 12,000 participants for five years.

Patients from the United States, Canada, Mexico, the Bahamas, Europe, South America, Australia, and New Zealand participated in the study, which lasted from January 2014 to June 2018.

According to the research, 7.7% of Belviq weight reduction patients were diagnosed with cancer. Only 7.1 percent of those in the placebo group got cancer.

Notably, the research discovered that the imbalance of cancer incidence grew when patients used lorcaserin for extended periods of time.

Users of the Belviq diet pill suffered a variety of malignancies, with pancreatic cancer, colorectal cancer, and lung cancer being among the most frequent.

Despite the fact that the study showed a potentially dangerous link between Belviq and cancer, the FDA is not presently suggesting that these individuals undergo further testing.

Instead, anybody who has used the Belviq diet pill should talk with their doctor if they have any queries or concerns.

If you or a loved one got cancer as a result of using the weight-loss medication Belviq, you may be entitled to compensation for your pain and suffering. To check whether you qualify, fill out the form on this page. 

The class action lawsuit questionnaire is a tool that helps people find out if they qualify for a class-action lawsuit. It was created by the law firm Belviq Cancer Side Effects Lawsuit Claim Review.

Frequently Asked Questions

Who qualifies for Zantac lawsuit?

Only people who have experienced gastritis, heartburn, or reflux.

What type of cancer does belviq cause?

Belviq is a medication that is used to treat hyperkalemia, which can be caused by cancer. It works by stimulating the kidneys ability to excrete potassium in the urine.

Can I still get belviq?

Yes, you can still get belviq.

Related Tags

  • class action settlement timeline
  • recall lawsuit
  • mortgage class action lawsuit
  • how to join a class action lawsuit
  • top class action lawsuit 2019